How should I evaluate and manage sensorineural hearing loss, including work‑up, treatment of sudden loss, and rehabilitation options?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Sensorineural Hearing Loss

Initial Evaluation: Distinguish SSNHL from Other Causes

Immediately perform Weber and Rinne tuning fork tests to differentiate sensorineural from conductive hearing loss, as this fundamentally determines the entire management pathway. 1, 2

  • Obtain formal audiometry within 24-48 hours (ideally within 14 days maximum) to confirm sensorineural hearing loss, defined as ≥30 dB loss at 3 consecutive frequencies occurring within 72 hours. 1, 2
  • Assess specifically for red flags requiring alternative workup: bilateral hearing loss, recurrent episodes, fluctuating hearing, focal neurologic symptoms (weakness, dysarthria, ataxia, diplopia), severe headache, or concurrent vestibular symptoms. 1, 3, 2
  • The combination of unilateral sensorineural hearing loss with unsteadiness is the classic presentation of vestibular schwannoma (94% of cases), which worsens prognosis for hearing recovery. 3

Immediate Treatment for Sudden Sensorineural Hearing Loss

Start oral prednisone 1 mg/kg/day (maximum 60 mg) as a single daily dose immediately for 7-14 days followed by taper—every day of delay worsens prognosis. 1, 2

  • Treatment initiated within 2 weeks shows benefit, but starting within 5 days demonstrates statistically significantly better outcomes than delayed treatment. 2, 4
  • Do not wait for MRI results before initiating steroids if sudden hearing loss is confirmed on audiometry. 3
  • Educate patients that 32-65% may recover spontaneously, but treatment improves outcomes, and the underlying cause remains unknown in 85-90% of cases. 1, 2

Workup for Retrocochlear Pathology

Order MRI of the brain with internal auditory canal sequences (with gadolinium) to evaluate for vestibular schwannoma and other retrocochlear pathology. 1, 3, 2

  • If MRI is contraindicated, obtain CT or auditory brainstem response (ABR) testing as alternatives. 1, 5
  • Do NOT order routine head CT scans—they are not useful for evaluating sudden sensorineural hearing loss. 1
  • Do NOT obtain routine laboratory tests in idiopathic sudden sensorineural hearing loss, as they lack benefit. 1

Salvage Therapy for Incomplete Recovery

If hearing recovery is incomplete at 2-6 weeks after initial oral steroid treatment, offer intratympanic steroid perfusion: 4-6 injections of dexamethasone over 2 weeks. 1, 2, 5

  • Intratympanic steroids can also be offered as primary therapy if oral steroids are contraindicated. 2, 5
  • Hyperbaric oxygen therapy may be considered only when combined with steroid therapy, initiated within 2 weeks for initial treatment or within 1 month for salvage therapy, though cost and limited availability make it impractical in most settings. 1, 5

Treatments to AVOID

Do NOT routinely prescribe antivirals, thrombolytics, vasodilators, vasoactive substances, or antioxidants—there is insufficient evidence supporting their use. 1, 5

Follow-Up and Rehabilitation

Obtain audiometric evaluation at the conclusion of treatment and again within 6 months to document final hearing status. 1, 2

  • The majority of recovery occurs within 1 month (90% of final hearing levels), with 98.3% reaching final levels by 3 months. 1
  • Counsel all patients with residual hearing loss or persistent tinnitus about hearing aids, assistive listening devices, and audiologic rehabilitation—initiate these discussions early as temporary measures may provide immediate benefit and reduce anxiety. 1, 2
  • Schedule at least annual audiometric monitoring for adults to assess hearing stability and amplification device function. 1

Prognostic Factors

Mid-frequency "flat" audiometric configuration shows the highest slight recovery rates compared to other patterns. 4

The presence of vertigo at onset significantly worsens prognosis for complete hearing recovery. 3, 6

Bilateral sudden sensorineural hearing loss has substantially worse outcomes (29% recovery in children, lower in adults) and should prompt evaluation for specific systemic causes including meningitis, autoimmune inner ear disease, Lyme disease, syphilis, ototoxic medications, or trauma. 1, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Immediate Management of Sudden Sensorineural Hearing Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Unilateral Sensorineural Hearing Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Controversies in the management of sudden sensorineural hearing loss: an evidence-based review.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2015

Research

Paediatric Sudden Sensorineural Hearing Loss: Pooled Analysis and Systematic Review.

The journal of international advanced otology, 2021

Related Questions

How is sensorineural hearing loss managed?
What is the recommended workup and management for a patient with asymmetric sensorineural hearing loss?
What is the best course of action for a patient with sudden sensorineural hearing loss (SSNHL) in one ear, who was recently treated with Rocephin (Ceftriaxone) for an ear infection, has a mildly retracted but otherwise normal tympanic membrane (TM), and a clear external ear canal (EEC), with no reported pain?
What is the typical timeline for improvement in sudden sensorineural hearing loss (SSNHL) with treatment, particularly in terms of edema reduction and nerve recovery?
What is the approach to differential diagnosis of sensorineural hearing loss?
What is the first‑line therapy for a patient with connective‑tissue‑disease‑associated usual interstitial pneumonia?
What is the appropriate management for a patient with elevated total cholesterol, elevated LDL cholesterol, and elevated triglycerides?
How should I evaluate and manage a man over 50 with benign prostatic hyperplasia and intraprostatic calculi presenting with lower urinary tract symptoms and recurrent prostatitis?
How should an adult male with a painful erection lasting more than four hours (priapism) be managed?
What are the differences between pegfilgrastim and filgrastim for prophylaxis of chemotherapy‑induced neutropenia, including dosing schedule, pharmacokinetics, cost, and preferred clinical use?
What is the recommended empiric treatment, testing, partner management, and follow‑up for acute honeymoon urethritis acquired after recent unprotected intercourse?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.